SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000902664-18-002549
Filing Date
2018-06-12
Accepted
2018-06-12 13:57:37
Documents
1
Period of Report
2018-06-11

Document Format Files

Seq Description Document Type Size
1 MIRATI THERAPEUTICS, INC. p18-1318form4.html 4  
1 MIRATI THERAPEUTICS, INC. p18-1318form4.xml 4 7976
  Complete submission text file 0000902664-18-002549.txt   9975
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 120 WEST 45TH STREET SUITE 2802 NEW YORK NY 10036
Business Address 120 WEST 45TH STREET SUITE 2802 NEW YORK NY 10036 212-937-4975
venBio Select Advisor LLC (Reporting) CIK: 0001633313 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 18894172

Mailing Address C/O VENBIO SELECT ADVISOR LLC 120 W. 45TH STREET, 28TH FLOOR NEW YORK NY 10036
Business Address
Aghazadeh Behzad (Reporting) CIK: 0001701815 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 18894173